- Home
- China
- World
- Asia-Pacific
- Americas
- Europe
- Middle-East and Africa
- Politics
- Business
- Opinions
- Tech & Sci
- Culture
- Sports
- Travel
- Nature
- Picture
- Video
- Live
- TV
- Radio
- Specials
- Learn Chinese
World
07:43, 01-Feb-2022
Moderna's COVID-19 vaccine gets FDA full approval
Share
Copied
Moderna's COVID-19 vaccine received full approval from the U.S. Food and Drug Administration (FDA) on Monday.
The vaccine, named Spikevax, is approved for use in people ages 18 and older.
Spikevax meets the FDA's rigorous standards for safety, effectiveness and manufacturing quality required for approval, said the agency in a statement.
Source(s): Xinhua News Agency
